Literature DB >> 25877499

Levels in plasma of the serine proteases and associated proteins of the lectin pathway are altered in patients with systemic lupus erythematosus.

Anne Troldborg1, Steffen Thiel2, Magdalena Janina Laska2, Bent Deleuran2, Jens Christian Jensenius2, Kristian Stengaard-Pedersen2.   

Abstract

OBJECTIVE: To examine whether proteins of the lectin pathway of the complement system are involved in systemic lupus erythematosus (SLE) pathogenesis.
METHODS: Using time-resolved immunofluorometric assays, plasma levels of mannan-binding lectin (MBL)-associated serine proteases 1 (MASP-1), MASP-2, MASP-3, MBL-associated protein of 19 kDa (MAp19), and MAp44 were determined in 58 patients with SLE and 65 healthy controls (HC).
RESULTS: Plasma concentrations in patients with SLE were higher than HC regarding MASP-1, MASP-3, and MAp44 (p < 0.0001, 0.0003, and 0.0013). Complement factor 3 correlated negatively and anti-dsDNA positively with levels of MAp19 (p = 0.0035, p = 0.0133).
CONCLUSION: In SLE, plasma levels of MASP and MAp are altered and associated with SLE characteristics, supporting a role in SLE pathogenesis.

Entities:  

Keywords:  COMPLEMENT SYSTEM; INNATE IMMUNITY; LECTIN PATHWAY; SYSTEMIC LUPUS ERYTHEMATOSUS

Mesh:

Substances:

Year:  2015        PMID: 25877499     DOI: 10.3899/jrheum.141163

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Plasma levels of H- and L-ficolin are increased in axial spondyloarthritis: improvement of disease identification.

Authors:  A Troldborg; S Thiel; C E Mistegaard; A Hansen; T-L Korsholm; K Stengaard-Pedersen; A G Loft
Journal:  Clin Exp Immunol       Date:  2019-10-01       Impact factor: 4.330

2.  Low level of MAp44, an inhibitor of the lectin complement pathway, and long-term graft and patient survival; a cohort study of 382 kidney recipients.

Authors:  Julia Smedbråten; Geir Mjøen; Anders Hartmann; Anders Åsberg; Halvor Rollag; Tom Eirik Mollnes; Leiv Sandvik; Morten W Fagerland; Steffen Thiel; Solbjørg Sagedal
Journal:  BMC Nephrol       Date:  2016-10-18       Impact factor: 2.388

3.  Association between endometriosis and risk of systemic lupus erythematosus.

Authors:  Yu-Hsi Fan; Pui-Ying Leong; Jeng-Yuan Chiou; Yu-Hsun Wang; Ming-Hsiang Ku; James Cheng-Chung Wei
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

4.  Characterization of DNA-protein complexes by nanoparticle tracking analysis and their association with systemic lupus erythematosus.

Authors:  Kristian Juul-Madsen; Anne Troldborg; Thomas R Wittenborn; Mads G Axelsen; Huaying Zhao; Lasse H Klausen; Stefanie Luecke; Søren R Paludan; Kristian Stengaard-Pedersen; Mingdong Dong; Holger J Møller; Steffen Thiel; Henrik Jensen; Peter Schuck; Duncan S Sutherland; Søren E Degn; Thomas Vorup-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-27       Impact factor: 11.205

5.  Frequency and distribution of FCN2 and FCN3 functional variants among MBL2 genotypes.

Authors:  Helga Bjarnadottir; Margret Arnardottir; Bjorn Runar Ludviksson
Journal:  Immunogenetics       Date:  2016-01-21       Impact factor: 2.846

6.  Essential Roles for Mannose-Binding Lectin-Associated Serine Protease-1/3 in the Development of Lupus-Like Glomerulonephritis in MRL/lpr Mice.

Authors:  Takeshi Machida; Natsumi Sakamoto; Yumi Ishida; Minoru Takahashi; Teizo Fujita; Hideharu Sekine
Journal:  Front Immunol       Date:  2018-05-28       Impact factor: 7.561

7.  Progressive IgA Nephropathy Is Associated With Low Circulating Mannan-Binding Lectin-Associated Serine Protease-3 (MASP-3) and Increased Glomerular Factor H-Related Protein-5 (FHR5) Deposition.

Authors:  Nicholas R Medjeral-Thomas; Anne Troldborg; Nicholas Constantinou; Hannah J Lomax-Browne; Annette G Hansen; Michelle Willicombe; Charles D Pusey; H Terence Cook; Steffen Thiel; Matthew C Pickering
Journal:  Kidney Int Rep       Date:  2017-11-29

8.  Association of MASP2 levels and MASP2 gene polymorphisms with systemic lupus erythematosus.

Authors:  Wang-Dong Xu; Xiao-Yan Liu; Lin-Chong Su; An-Fang Huang
Journal:  J Cell Mol Med       Date:  2020-07-17       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.